Stock listing
NASDAQ:ABII Abraxis BioScience Inc Stock
Follow Abraxis BioScience Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ABII
$78.25 USD
Close on Oct 15, 2010 · No longer trades
- Lowest – highest close
- $25.16 – $78.30 USDSince Nov 14, 2007 · lowest Sep 3, 2009 · highest Oct 14, 2010
Delisted NASDAQ:ABII no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ABII
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Abraxis BioScience Inc on 6ix
- Decks
- 2 decks · latest Jul 30, 2010
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2010 Earnings Presentation | Earnings | 7 slides | Jul 30, 2010 |
| Merger or Acquisition (June 2010) | Merger or acquisition | 25 slides | Jun 30, 2010 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Mary Lynne Hedley Other companies: Eli Lilly and Company (Director · Since at least May 15, 2022); Centessa Pharmaceuticals PLC (Director · Since at least May 27, 2021); Veeva Systems Inc. (Director · Since at least Aug 16, 2019); Tempest Therapeutics, Inc. (Director · Dec 7, 2018 – Jun 22, 2020 · Past); Bluebird bio Inc (Director · Sep 18, 2017 – Jun 20, 2018 · Past); Receptos Inc (Director · Apr 11, 2014 – Aug 27, 2015 · Past); Tesaro Inc (President & COO, Director · Jun 27, 2012 – Jan 22, 2019 · Past) | Executive VP of Ops & CSO · Jul 9, 2009 – Jul 13, 2009 · Past |
Log in to ask 6ix AI your own questions about Abraxis BioScience Inc.